SCGB1A1 and chronic obstructive pulmonary disease: Further longitudinal studies with FOT and other diagnostic tools including spirometry and blood markers (like matrix metalloproteinase MMPS and its inhibitors, and club cell protein 16 (CC16)) comparing smokers and non-smokers for the development of COPD and other respiratory pathologies can be useful for understanding disease progression.